Innate Pharma (IPHA) Q4 2023 Earnings Report

157 Followers

IPHA Q4 2023 EPS Results

Actual EPS-$0.13

Consensus EPS-$0.44

Beat/MissBeat by +$0.31

One Year Ago EPS-$0.88

Actual Revenue$17.91M

Expected Revenue$18.15M

Beat/MissMissed by -$240.20K

YoY Revenue Growth+112.69%

QuarterQ4 2023

Date03/21/2024

TimeBefore Open

Conference CallThursday, March 21, 2024

IPHA Upcoming Earnings

Innate Pharma's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

IPHA Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 25, 2027	2026 (Q4)	-0.29 / -	-0.358	―
Sep 17, 2026	2026 (Q2)	-0.18 / -0.24	-0.296	18.58% (+0.05)
Mar 26, 2026	2025 (Q4)	-0.14 / -0.36	-0.346	-3.47% (-0.01)
Sep 17, 2025	2025 (Q2)	-0.33 / -0.30	-0.342	13.45% (+0.05)
Mar 27, 2025	2024 (Q4)	-0.27 / -0.35	-0.13	-166.15% (-0.22)
Sep 12, 2024	2024 (Q2)	-0.30 / -0.34	0.021	-1728.57% (-0.36)
Mar 21, 2024	2023 (Q4)	-0.44 / -0.13	-0.88	85.23% (+0.75)
Sep 14, 2023	2023 (Q2)	0.09 / 0.02	0.08	-73.75% (-0.06)
Mar 23, 2023	2022 (Q4)	-0.41 / -0.88	-0.378	-132.80% (-0.50)
Sep 15, 2022	2022 (Q2)	0.38 / 0.08	-0.355	122.54% (+0.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed